Literature DB >> 1743489

Low nucleotide diversity in man.

W H Li1, L A Sadler.   

Abstract

The nucleotide diversity (pi) in humans is studied by using published cDNA and genomic sequences that have been carefully checked for sequencing accuracy. This measure of genetic variability is defined as the number of nucleotide differences per site between two randomly chosen sequences from a population. A total of more than 75,000 base pairs from 49 loci are compared. The DNA regions studied are the 5' and 3' untranslated regions and the amino acid coding regions. The coding regions are divided into nondegenerate sites (i.e., sites at which all possible changes are nonsynonymous), twofold degenerate sites (i.e., sites at each of which one of the three possible changes is synonymous) and fourfold degenerate sites (i.e., sites at which all three possible changes are synonymous). The pi values estimated are, respectively, 0.03 and 0.04% for the 5' and 3' UT regions, and 0.03, 0.06 and 0.11% for nondegenerate, twofold degenerate and fourfold degenerate sites. Since the highest pi value is only 0.11%, which is about one order of magnitude lower than those in Drosophila populations, the nucleotide diversity in humans is very low. The low diversity is probably due to a relatively small long-term effective population size rather than any severe bottleneck during human evolution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743489      PMCID: PMC1204640     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  106 in total

1.  Brain cDNA clone for human cholinesterase.

Authors:  C McTiernan; S Adkins; A Chatonnet; T A Vaughan; C F Bartels; M Kott; T L Rosenberry; B N La Du; O Lockridge
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  cDNA sequence coding for human glutathione peroxidase.

Authors:  Y Sukenaga; K Ishida; T Takeda; K Takagi
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

3.  Nucleotide sequence of the human APRT gene.

Authors:  Y Hidaka; S A Tarlé; T E O'Toole; W N Kelley; T D Palella
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

4.  Nucleotide sequence of a human gene for glutathione peroxidase.

Authors:  K Ishida; T Morino; K Takagi; Y Sukenaga
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

Review 5.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

6.  Structure of the human vasoactive intestinal polypeptide gene.

Authors:  T Tsukada; S J Horovitch; M R Montminy; G Mandel; R H Goodman
Journal:  DNA       Date:  1985-08

7.  Primary structure of human ribosomal protein S14 and the gene that encodes it.

Authors:  D D Rhoads; A Dixit; D J Roufa
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

8.  Isolation of a cDNA clone encoding pancreatic polypeptide.

Authors:  T Takeuchi; T Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression.

Authors:  V Jonas; C R Lin; E Kawashima; D Semon; L W Swanson; J J Mermod; R M Evans; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin.

Authors:  S F Ziegler; J D Marth; D B Lewis; R M Perlmutter
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

View more
  122 in total

1.  The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data.

Authors:  L B Jorde; W S Watkins; M J Bamshad; M E Dixon; C E Ricker; M T Seielstad; M A Batzer
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Mining SNPs from EST databases.

Authors:  L Picoult-Newberg; T E Ideker; M G Pohl; S L Taylor; M A Donaldson; D A Nickerson; M Boyce-Jacino
Journal:  Genome Res       Date:  1999-02       Impact factor: 9.043

3.  SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity.

Authors:  S Gaudieri; R L Dawkins; K Habara; J K Kulski; T Gojobori
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

4.  The signature of positive selection at randomly chosen loci.

Authors:  Molly Przeworski
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

5.  Contrasting patterns of polymorphisms at the ABO-secretor gene (FUT2) and plasma alpha(1,3)fucosyltransferase gene (FUT6) in human populations.

Authors:  Y Koda; H Tachida; H Pang; Y Liu; M Soejima; A A Ghaderi; O Takenaka; H Kimura
Journal:  Genetics       Date:  2001-06       Impact factor: 4.562

6.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

Review 7.  Use of single nucleotide polymorphisms for gene discovery in hypertension.

Authors:  M Fornage; P A Doris
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

8.  The implications of intergenic polymorphism for major histocompatibility complex evolution.

Authors:  C O'hUigin; Y Satta; A Hausmann; R L Dawkins; J Klein
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

9.  Structural analysis of insulin minisatellite alleles reveals unusually large differences in diversity between Africans and non-Africans.

Authors:  John D H Stead; Alec J Jeffreys
Journal:  Am J Hum Genet       Date:  2002-10-28       Impact factor: 11.025

Review 10.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.